BRPI1015538A2 - new formulation of naproxen - Google Patents

new formulation of naproxen

Info

Publication number
BRPI1015538A2
BRPI1015538A2 BRPI1015538A BRPI1015538A BRPI1015538A2 BR PI1015538 A2 BRPI1015538 A2 BR PI1015538A2 BR PI1015538 A BRPI1015538 A BR PI1015538A BR PI1015538 A BRPI1015538 A BR PI1015538A BR PI1015538 A2 BRPI1015538 A2 BR PI1015538A2
Authority
BR
Brazil
Prior art keywords
naproxen
new formulation
compositions
methods
medicaments
Prior art date
Application number
BRPI1015538A
Other languages
Portuguese (pt)
Inventor
Dodd Aaron
Russell Adrian
Meiser Felix
Norret Marck
H Bosch William
Original Assignee
Iceutica Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009901746A external-priority patent/AU2009901746A0/en
Application filed by Iceutica Pty Ltd filed Critical Iceutica Pty Ltd
Priority claimed from PCT/AU2010/000470 external-priority patent/WO2010121326A1/en
Publication of BRPI1015538A2 publication Critical patent/BRPI1015538A2/en

Links

Abstract

formulação de naproxeno a presente invenção refere-se a métodos para produzir partículas de naproxeno utilizando processos de moagem a seco, bem como composições que compreendem naproxeno, medicamentos produzidos usando naproxeno em forma de partículas e/ou composições, e métodos de tratamento de um animal, incluindo o ser humano, usando uma quantidade terapeuticamente eficaz de naproxeno administrada por meio de ditos medicamentos.Naproxen Formulation The present invention relates to methods for producing naproxen particles using dry milling processes, as well as compositions comprising naproxen, medicaments made using particulate naproxen and / or compositions, and methods of treating an animal including the human using a therapeutically effective amount of naproxen administered by said medicaments.

BRPI1015538A 2009-04-24 2010-04-23 new formulation of naproxen BRPI1015538A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17228909P 2009-04-24 2009-04-24
AU2009901746A AU2009901746A0 (en) 2009-04-24 A Novel Formulation of Naproxen
PCT/AU2010/000470 WO2010121326A1 (en) 2009-04-24 2010-04-23 A novel formulation of naproxen

Publications (1)

Publication Number Publication Date
BRPI1015538A2 true BRPI1015538A2 (en) 2019-04-09

Family

ID=67251389

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1015538A BRPI1015538A2 (en) 2009-04-24 2010-04-23 new formulation of naproxen

Country Status (1)

Country Link
BR (1) BRPI1015538A2 (en)

Similar Documents

Publication Publication Date Title
BRPI1014275B8 (en) composition comprising indomethacin particles dispersed in at least two partially ground mill materials
BRPI1014278B8 (en) method for producing a dosage form comprising metaxolone, dosage form, pharmaceutical composition comprising said dosage form and use thereof
PH12015500301A1 (en) A novel formulation of diclofenac
TN2011000536A1 (en) A novel formulation of naproxen
PH12016500746B1 (en) A novel formulation of meloxicam
EA201201648A1 (en) SGC STIMULATORS
BRPI1014276B8 (en) production of encapsulated nanoparticles on a commercial scale
CU20120161A7 (en) 5-FLUORO-1H-SUBSTITUTED PIRAZOLOPIRIDINS
ECSP13012668A (en) 1-BENCILCICLOALQUILCARBOXÍLICOS ACIDS SUBSTITUTED AND ITS USE
BR112015001638A2 (en) ketocoumarin as photoinitiators and photosensitizers in paints
BR112013026680A2 (en) compound, method of treating an inflammatory disease and pharmaceutical composition
BR112012019920A2 (en) pyridazine derivatives useful as cannabinoid-2 agonists.
BR112014030992A2 (en) compositions comprising calcogenides and related methods
BRPI1015538A2 (en) new formulation of naproxen
AU2014208310B2 (en) A Novel Formulation of Diclofenac
BR112012027788A2 (en) pharmaceutical composition and method for treating disease
MX2008011017A (en) Sigma receptor compounds.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2519 DE 16-04-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]